Swedish Orphan Biovitrum AB (publ)

BATS-CHIXE:SOBIS Stock Report

Market Cap: kr91.8b

Swedish Orphan Biovitrum Management

Management criteria checks 3/4

Swedish Orphan Biovitrum's CEO is Guido Oelkers, appointed in May 2017, has a tenure of 7.08 years. total yearly compensation is SEK48.88M, comprised of 25.1% salary and 74.9% bonuses, including company stock and options. directly owns 0.13% of the company’s shares, worth SEK115.32M. The average tenure of the management team and the board of directors is 5.4 years and 3.6 years respectively.

Key information

Guido Oelkers

Chief executive officer

kr48.9m

Total compensation

CEO salary percentage25.1%
CEO tenure7.1yrs
CEO ownership0.1%
Management average tenure5.4yrs
Board average tenure3.6yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Guido Oelkers's remuneration changed compared to Swedish Orphan Biovitrum's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024n/an/a

kr2b

Dec 31 2023kr49mkr12m

kr2b

Sep 30 2023n/an/a

kr3b

Jun 30 2023n/an/a

kr3b

Mar 31 2023n/an/a

kr3b

Dec 31 2022kr47mkr11m

kr3b

Sep 30 2022n/an/a

kr2b

Jun 30 2022n/an/a

kr3b

Mar 31 2022n/an/a

kr3b

Dec 31 2021kr42mkr10m

kr3b

Sep 30 2021n/an/a

kr3b

Jun 30 2021n/an/a

kr3b

Mar 31 2021n/an/a

kr3b

Dec 31 2020kr33mkr10m

kr3b

Sep 30 2020n/an/a

kr3b

Jun 30 2020n/an/a

kr3b

Mar 31 2020n/an/a

kr4b

Dec 31 2019kr33mkr10m

kr3b

Sep 30 2019n/an/a

kr3b

Jun 30 2019n/an/a

kr3b

Mar 31 2019n/an/a

kr3b

Dec 31 2018kr26mkr9m

kr2b

Sep 30 2018n/an/a

kr2b

Jun 30 2018n/an/a

kr2b

Mar 31 2018n/an/a

kr1b

Dec 31 2017kr16mkr5m

kr1b

Compensation vs Market: Guido's total compensation ($USD4.65M) is above average for companies of similar size in the UK market ($USD3.19M).

Compensation vs Earnings: Guido's compensation has been consistent with company performance over the past year.

CEO

Guido Oelkers (59 yo)

7.1yrs

Tenure

kr48,883,000

Compensation

Dr. Guido Oelkers is a Director of Dova Pharmaceuticals Inc. since November 12, 2019. Dr. Oelkers has been the Chief Executive Officer and President at Swedish Orphan Biovitrum AB since May 22, 2017. He se...

Leadership Team

NamePositionTenureCompensationOwnership
Guido Oelkers
CEO & President7.1yrskr48.88m0.13%
SEK 115.3m
Henrik Stenqvist
Chief Financial Officer5.9yrsno data0.017%
SEK 15.2m
Torbjörn Hallberg
General Counsel & Head of Legal Affairs5.4yrsno data0.0090%
SEK 8.2m
Daniel Rankin
Head of Strategy & Corporate Development2.4yrsno data0.0052%
SEK 4.8m
Lena Bjurner
Head of Human Resources1.4yrsno datano data
Armin Reininger
Senior Scientific & Medical Advisor7.4yrsno data0.0049%
SEK 4.5m
Norbert Oppitz
Head of International6.7yrsno data0.012%
SEK 10.7m
Sofiane Fahmy
Head of Europe5.4yrsno data0.0078%
SEK 7.2m
Duane Barnes
Head of North America3.4yrsno datano data
Mahmood Ladha
Head of Strategic Transformation Operationsno datano data0.0018%
SEK 1.7m
Christine Wesstrom
Head of Technical Operations2.3yrsno data0.0032%
SEK 3.0m
Lydia Abad-Franch
Senior VP1.4yrsno datano data

5.4yrs

Average Tenure

56.5yo

Average Age

Experienced Management: SOBIS's management team is seasoned and experienced (5.4 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Hans Wigzell
Chairman of Scientific Advisory Board23.4yrskr158.00kno data
Helena Saxon
Director13.2yrskr828.00k0.0067%
SEK 6.2m
Anders Ullman
Director1.1yrskr463.00k0.0010%
SEK 926.8k
Stephen O'Rahilly
Member of Scientific Advisory Boardno datano datano data
Ralf Pettersson
Member of Scientific Advisory Boardno datano datano data
Stefan Del Prato
Member of Scientific Advisory Boardno datano datano data
Jonathan Sanders Arch
Member of Scientific Advisory Boardno datano datano data
Annette Clancy
Independent Chairman10.1yrskr770.00k0.0010%
SEK 917.6k
Staffan Schuberg
Independent Director4.1yrskr827.00k0.0021%
SEK 1.9m
Filippa Stenberg
Director3.1yrskr673.00k0.00017%
SEK 156.0k
Katy Mazibuko
Employee Representative Director1.4yrsno data0.0018%
SEK 1.6m
Christophe Bourdon
Independent Director1.1yrskr433.00kno data

3.6yrs

Average Tenure

54.5yo

Average Age

Experienced Board: SOBIS's board of directors are considered experienced (3.6 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.